Heidi Hagen Alaunos Therapeutics, Inc. (TCRT) insider trading activity

TCRT Quotes by TradingView

Heidi Hagen is Director of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 145,889 shares of TCRT, which is worth approximately $303,449. The most recent transaction as insider was on Sep 02, 2021, when has been sold 23,770 shares (Common Stock) at a price of $1.76 per share, resulting in proceeds of $41,835. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 146K
0% 3M change
0% 12M change
Total Value Held $303,449

Heidi Hagen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 02 2021
BUY
Open market or private purchase
$41,835 $1.76 p/Share
23,770 Added 14.01%
145,889 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
90,000 Added 42.43%
122,119 Common Stock

Also insider at

VCEL
Vericel Corp Healthcare
HH

Heidi Hagen

Director
Cambridge, MA

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRT